Discuss This Drug

Propranolol

CHEBI:CHEBI_8499

Definition

A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Chemical Information

Molecular Formula
C16H21NO2
Molecular Mass
259.34348
Charge
0
SMILES
CC(C)NCC(O)COc1cccc2ccccc12
InChI
InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N

Alternative Names

  • 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
  • 1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
  • 3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
  • beta-Propranolol
  • Propanalol
  • Propanolol
  • propranolol
  • Propranolol
  • propranololo
  • propranololum

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:8499
DRON_00010000
8787
oboInOwl#hasDbXref
Wikipedia:Propranolol

Additional References

Wikipedia:Propranolol

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

package_ndc
62559-533-01
product_ndc
82804-073
listing_expiration_date
20241231
spl_id
ef9e397c-7bca-4a0c-92e4-31dcb5057d9b
marketing_start_date
20170428
package_description
1000 TABLET in 1 BOTTLE (63629-2274-1)
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
dosage_form
CAPSULE, EXTENDED RELEASE
labeler_name
Pierre Fabre Pharmaceuticals, Inc.
application_number
ANDA070218
active_ingredient_strength
4.28 mg/mL
active_ingredient_name
PROPRANOLOL
spl_set_id
d17f1a94-e4a7-403a-8f9c-42740751bee9
rxcui
1495064
manufacturer_name
Pierre Fabre Pharmaceuticals, Inc.
unii
F8A3652H1V
package_marketing_start_date
19860513
route
INTRAVENOUS
brand_name_suffix
ER
core#notation
CHEBI:8499
pharm_class
beta-Adrenergic Blocker [EPC]
upc
0372789280301
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
8787
oboInOwl#hasDbXref
Wikipedia:Propranolol
oboInOwl#id
CHEBI:8499
brand_name
Propranolol hydrochloride
brand_name_base
Propranolol hydrochloride
generic_name
Propranolol hydrochloride
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_35530
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_10319
BFO_0000053
http://purl.obolibrary.org/obo/DRON_00020323
has_treatment
http://purl.obolibrary.org/obo/DOID_0060084
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect36782
owl#annotatedSource
t310971
owl#someValuesFrom
t2990512